IGM Biosciences, Inc.
NASDAQ:IGMS
1.39 (USD) • At close March 11, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Omzet
| 2.679 | 2.13 | 1.069 | 0 | 0 | 0 | 0 | 0 |
| Kosten van de omzet
| 0 | 8.277 | 10.602 | 7.724 | 3.576 | 2.333 | 0.278 | 0.161 |
| Brutowinst
| 2.679 | -6.147 | -9.533 | -7.724 | -3.576 | -2.333 | -0.278 | -0.161 |
| Brutowinstmarge
| 1 | -2.886 | -8.918 | 0 | 0 | 0 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 160.854 | 215.519 | 179.289 | 127.026 | 65.03 | 35.257 | 18.962 | 8.639 |
| Algemene en administratieve kosten
| 50.405 | 50.072 | 49.736 | 38.297 | 18.25 | 9.241 | 3.829 | 2.508 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 50.405 | 50.072 | 49.736 | 38.297 | 18.25 | 9.241 | 3.829 | 2.508 |
| Overige kosten
| 0 | 0 | -0.181 | 0.159 | 1.925 | 1.365 | 0.08 | 0.093 |
| Bedrijfskosten
| 211.259 | 265.591 | 229.025 | 165.323 | 83.28 | 44.498 | 22.791 | 11.147 |
| Bedrijfsresultaat
| -208.58 | -263.461 | -227.956 | -165.323 | -83.28 | -44.498 | -22.791 | -11.147 |
| Bedrijfsresultaat ratio
| -77.857 | -123.691 | -213.242 | 0 | 0 | 0 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| 12.785 | 17.723 | 6.854 | 0.159 | 1.925 | 1.365 | 0.08 | 0.093 |
| Inkomen voor belasting
| -195.795 | -245.738 | -221.102 | -165.164 | -81.355 | -43.133 | -22.711 | -11.054 |
| Inkomen voor belasting ratio
| -73.085 | -115.37 | -206.831 | 0 | 0 | 0 | 0 | 0 |
| Belastingkosten
| 0 | 0.678 | -6.854 | -4.484 | -1.025 | -0.597 | 0.08 | 0 |
| Nettowinst
| -195.795 | -246.416 | -214.248 | -160.68 | -80.33 | -42.536 | -22.711 | -11.054 |
| Nettowinstmarge
| -73.085 | -115.688 | -200.419 | 0 | 0 | 0 | 0 | 0 |
| WPA (Winst Per Aandeel)
| -3.24 | -4.71 | -5.16 | -4.8 | -2.61 | -4.73 | -51.84 | -25.24 |
| Verwaterde WPA
| -3.24 | -4.71 | -5.16 | -4.8 | -2.61 | -4.73 | -51.84 | -25.24 |
| EBITDA
| -208.58 | -253.358 | -221.881 | -157.44 | -77.779 | -40.8 | -22.513 | -10.986 |
| EBITDA ratio
| -77.857 | -118.947 | -213.242 | 0 | 0 | 0 | 0 | 0 |